Results
Marksans Pharma Q2 Revenue Hits Record ₹940 Crore
Marksans Pharma reported unaudited Q2FY27 standalone and consolidated results, with record quarterly revenue of ₹940 crore, up 30.5% YoY.
Q2 EBITDA surged 48.3% to ₹214 crore, while H1FY27 PAT nearly
